More than 89 lakh COVID-19 vaccine doses are still available with the States and UTs and over 28 lakh vaccine doses will be received by them within the next three days, the Union Health Ministry said
Updated:
May 05, 2021 15:19 IST
This is the first time that a local body in Kerala is putting up such a system to provide doorstep medical service
Share Article
AAA
People wait for COVID-19 antigen tests, amid the ongoing second wave of coronovirus pandemic, in Thiruvananthapuram, Kerala on May 4, 2021.
| Photo Credit:
PTI
This is the first time that a local body in Kerala is putting up such a system to provide doorstep medical service
With many COVID-19 asymptomatic patients now in home quarantine than in hospitals or first line treatment centres, the Thiruvananthapuram Corporation is set to deploy medical teams to check on them at their homes and also make available telemedicine facilities.
Updated:
May 05, 2021 18:09 IST
Uttar Pradesh government said it noticed a trend where the number of people getting discharged was less than the daily positive cases
Share Article
AAA
People over 18 year of age wait in a queue for a shot of first dose of vaccine against COVID-19, outside Moti Lal Nehru Medical College in Prayagraj, Uttar Pradesh on May 05, 2021.
| Photo Credit:
PTI
Uttar Pradesh government said it noticed a trend where the number of people getting discharged was less than the daily positive cases Over 51,000 persons in the age group of 18-44 have been administered the first dose of COVID-19 vaccine in Uttar Pradesh since the drive started on May 1, the State government said on Wednesday. The exact official figure stood at 51,284.
Updated:
May 03, 2021 12:52 IST
“We are deeply concerned by the critical COVID-19 situation in India, and our hearts go out to you, your loved ones and all the people of India,” says Pfizer Chairman and CEO Albert Bourla
Share Article
AAA
File photo of Pfizer company logo at the company’s headquarters in New York. | Photo Credit: AP
“We are deeply concerned by the critical COVID-19 situation in India, and our hearts go out to you, your loved ones and all the people of India,” says Pfizer Chairman and CEO Albert Bourla Global pharma major Pfizer is sending its medicines worth $70 million (over ₹510 crore), from its distribution centres in the U.S., Europe and Asia, that have been identified as part of India’s COVID-19 treatment protocol, the company’s Chairman and CEO Albert Bourla said on May 3.